Overview

Vita Genomics Inc. aims to become a premier genomics-based company focused on improving biological products and understanding diseases prevalent in the Asia Pacific region. The company is in the process of creating an Asia-specific cSNP database as well as a disease-oriented genomic sequence database and a collection of specialized patient samples.

In that effort, Vita Genomics has employed Celera Genomic’s integrated database products, bioinformatics systems and other discovery tools. The resulting cSNP database will serve as a tool for pharmaceutical companies and contract research organization to improve clinical trial results, enhance drug efficacy and minimize toxicity.

Vita Genomics also has a U.S. bioinformatics subsidiary located in Burlingame, Calif.